Ownership history in ASSETMARK, INC · 1 quarter on record
This page tracks every 13F SEC filing in which ASSETMARK, INC reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | INITIATED | 888 | — | — | 0.00% | $6K | $7.17 |
As of 2025 Q4 — sorted by position size